1 / 8

Pharmacovigilance Market Trend will witness a sustainable 10.3% growth

Get more details @ http://bit.ly/2pNCVFp <br>Major industry players of pharmacovigilance market include Boehringer Ingelheim, Accenture, Bristol-Myers Squibb, Covance, ICON, PAREXEL, Quintiles, United BioSource, Synowlwedge and Cognizant Technology Solutions Corporation.

jueekate
Télécharger la présentation

Pharmacovigilance Market Trend will witness a sustainable 10.3% growth

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pharmacovigilance Market share to exceed $8bn by 2024: Fractovia.org Fuel Cell Market size worth $25.5bn by 2024

  2. Key Insights ofPharmacovigilance Market: • Pharmacovigilance Market will generate a revenue of more than USD 8 billion by 2024. • Pharmacovigilance market is trending toward a remarkable growth path, owing to the presence of global organizations such as WHO, that undertake the responsibility to monitor the safety and effects of licensed drugs. • Stringent government rules pertaining to the approval of drugs and their safety will also influence pharmacovigilance industry share considerably. • Contract outsourcing segment accounted for more than 50% of market share in 2015, and is anticipated to collect a revenue of more than USD 4.8 billion by 2024. • Based on the clinical trial trends, pharmacovigilance industry is mainly divided into phase I, preclinical, phase II, phase III, and phase IV. Phase IV clinical trial was worth USD 2.4 billion in 2015 and will record an annual growth rate of 10.9% over the coming years of 2016 to 2024, primarily driven by rising concerns among the public regarding the safety and adverse effects of drug events.

  3. Continued… • Europe pharmacovigilance industry was worth USD 793 million in 2015 and will collect a revenue of USD 1.8 billion by 2024, with an annual growth rate of 9.9% over the coming seven years. • Asia Pacific pharmacovigilance market collected a revenue of USD 835 million in 2015 and will surpass a revenue collection of USD 2.4 billion by 2024, owing to the implementation of stringent health care norms along with the presence of a huge patient base across this region. • U.S. pharmacovigilance industry share will register a CAGR of 10.7% over the period of 2016 to 2024. • Many of the market players are willing to sign strategic partnerships with contract research organizations to provide customized services. • The key participants in pharmacovigilance market are Accenture, Covance, BoehringerIngelheim, PAREXEL, Bristol-Myers Squibb, United BioSource Corporation, Cognizant Technology Solutions Corporation, Quintiles, and ICON plc.

  4. U.S. Pharmacovigilance Market size, by service provider, 2012- 2024 (USD Million)

  5. Browse Full Market Research Report of Pharmacovigilance Market @ http://bit.ly/2pd5Kas Request for a Sample of this Research report @ https://www.fractovia.org/request-sample/388

  6. Table of Contents: Chapter 1. Methodology and Scope 1.1. Research Methodology 1.1.1. Initial data exploration 1.1.2. Statistical modeling and forecast 1.1.3. Industry insights and validation 1.1.4. Research scope and assumptions 1.2. Data Sources 1.2.1. Primary Sources 1.2.2. Secondary Sources Chapter 2. Executive Summary 2.1. Pharmacovigilance industry 3600 synopsis, 2012 - 2024 2.1.1. Business trends 2.1.2. End user trends 2.1.3. Regional trends Chapter 3. Pharmacovigilance Industry Insights 3.1. Industry segmentation 3.2. Industry size and forecast, 2012 - 2024

  7. Continued… 3.3. Industry impact forces 3.3.1. Growth drivers 3.3.1.1. Increase in adoption rate of outsourcing services 3.3.1.2. Increasing consumption of drugs 3.3.1.3. Rise in adverse drug reactions (ADR) and drug toxicity 3.3.2. Industry pitfalls & challenges 3.3.2.1. Dearth of availability of skilled personnel 3.3.2.2. High risk associated with data security 3.4. Growth potential analysis 3.4.1. New business models 3.5. Porter’s analysis 3.6. Regulatory Landscape 3.7. Pharmacovigilance Reporting system 3.8. Company market share analysis, 2015 3.8.1. Strategy dashboard 3.9. PESTEL analysis

  8. Stay In Touch Website: https://www.fractovia.org Social Media:

More Related